{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:46:13Z","timestamp":1788201973969,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"s5","license":[{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In patients with gastro\u2010oesophageal reflux disease, the pH of refluxed gastric contents has a direct bearing on disease severity and oesophageal damage. A pH of 4 has been defined as a threshold below which refluxed gastric contents become injurious to the oesophagus. Studies in patients with erosive oesophagitis have shown that the 8\u2010week healing rates produced by acid suppressive therapy are related to the duration of time over a 24\u2010h period that the intragastric pH\u2003&gt;\u20034. The most effective agents, providing more hours with gastric pH\u2003&gt;\u20034 and higher healing rates in erosive oesophagitis patients, are the proton pump inhibitors. The intragastric pH is often used to gauge the efficacy of acid suppressive therapies. There are several factors, however, that may affect the clinical relevance of such data, and these should be taken into account when comparing the effectiveness of different therapies. Firstly, because of inter\u2010individual variation, studies comparing therapies should be of a crossover design, so that responses to therapy are measured in the same individuals. Secondly, the <jats:italic>Helicobacter pylori<\/jats:italic> status of the individual should be known, as <jats:italic>H. pylori<\/jats:italic> infection has been shown to increase intragastric pH readings when examining the effect of acid suppressive therapy. Other factors, such as positioning of the pH electrode and the duration of previous therapy, also need to be standardized when using intragastric pH to assess the efficacy of different therapies. Crossover studies comparing standard doses of different proton pump inhibitors have shown that esomeprazole 40\u2003mg produces a significantly greater amount of time at intragastric pH\u2003&gt;\u20034 on day 5 of treatment than standard doses of other proton pump inhibitors. The correlation between greater efficacy in acid suppression and clinical benefit is supported by the findings that esomeprazole 40\u2003mg is the only proton pump inhibitor to provide greater 8\u2010week healing rates in patients with erosive oesophagitis than both omeprazole and lansoprazole. These data all suggest strongly that intragastric pH monitoring is an effective surrogate marker and a relevant predictor of outcome in gastro\u2010oesophageal reflux disease.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02140.x","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T08:49:09Z","timestamp":1096447749000},"page":"19-26","source":"Crossref","is-referenced-by-count":59,"title":["Review article: gastric pH \u2014 the most relevant predictor of benefit in reflux disease?"],"prefix":"10.1111","volume":"20","author":[{"given":"D.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.8.1020"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.2008.S1"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90062-P"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_8_6_2","first-page":"G357","article-title":"Spatiotemporal characteristics of physiological gastroesophageal reflux","volume":"266","author":"Weusten BL","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_8_7_2","first-page":"167","article-title":"Long\u2010term ambulatory gastric pH\u2010metry: easy to do but difficult to analyze","volume":"1","author":"Armstrong D","year":"1989","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91015-X"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1990.tb00445.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529008997637"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(94)94341-9"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31876"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01743.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90374-7"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.4.539"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.6.743"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608881"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.9.1177"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.3.240"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.9.957"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00813.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015009300955"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)82157-5"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(01)02876-3"},{"key":"e_1_2_8_25_2","first-page":"A63(Abstract","article-title":"Esomeprazole 40 mg provides more effective acid control than rabeprazole 20 mg","volume":"47","author":"Wilder\u2010Smith C","year":"2000","journal-title":"Gut"},{"key":"e_1_2_8_26_2","first-page":"A200(Abstract","article-title":"Esomeprazole 40 mg provides faster and more effective acid control than lansoprazole 30 mg in patients with symptoms of gastroesophageal reflux disease","volume":"122","author":"Wilder\u2010Smith C","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_8_27_2","first-page":"A63(Abstract","article-title":"Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg during single and repeated administration","volume":"47","author":"Thomson ABR","year":"2000","journal-title":"Gut"},{"key":"e_1_2_8_28_2","first-page":"A62","article-title":"Esomeprazole 20 mg provides faster and more effective acid control than lansoprazole 15 mg","volume":"47","author":"Wilder\u2010Smith C","year":"2000","journal-title":"Gut"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08783.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)82245-X"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01496.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01128.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01087.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00856.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03600.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05532.x"},{"key":"e_1_2_8_38_2","first-page":"A241(Abstract","article-title":"A comparison of esomeprazole 40 mg once\u2010daily and pantoprazole 40 mg once\u2010daily for the healing of reflux oesophagitis","volume":"52","author":"Labenz J","year":"2003","journal-title":"Gut"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03443.x"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01024.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01464.x"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011212"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199802000-00004"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04237.x"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00198.x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii31"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.6.885"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02140.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:46:33Z","timestamp":1695732393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02140.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,29]]},"references-count":47,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02140.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02140.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,29]]}}}